论文部分内容阅读
目的:就哮喘性支气管炎患者,按照普米克令舒和可必特雾化吸入的方式进行治疗的实际效果进行分析。方法:两组患者在传统的常规治疗方案的基础上,对照组用普米克令舒药物对患者进行单一的药物治疗,观察组在本次治疗中,则需要辅助使用可必特雾化吸入治疗,再对比分析两组数据。结果:综合对两组患者在本次治疗中疗效进行分析可以发现,观察组整体治疗有效率高达98.33%,共涉及到显效患者42例以及有效患者17例,而对照组整体治疗有效率仅为68.33%,主要涉及显效患者19例,有效患者22例,综合对比发现,数据间存在显著差异(P<0.05)。且观察组各方面指标消失时间同样短于对照组(P<0.05)。结论:普米克令舒和可必特两种药物联合使用(雾化吸入),对治疗哮喘性支气管炎的临床疗效达到了理想的效果,其利用价值较大,效果较明显。
PURPOSE: To analyze the actual effects of treatment with asthma bronchitis on the basis of pulmicort and niacin inhalation. Methods: The two groups of patients on the basis of the conventional routine treatment, the control group with pulmicort patients on a single drug treatment, the observation group in this treatment, you need to assist the use of essential atomized inhalation therapy , Then compare two sets of data. Results: The comprehensive analysis of the curative effect of the two groups of patients in this treatment can be found in the observation group, the overall treatment efficiency as high as 98.33%, involving a total of 42 cases of effective and 17 cases of effective patients, while the control group, the overall treatment effective rate was only 68.33%, mainly in 19 cases of effective patients, 22 cases of effective patients, a comprehensive comparison found significant differences between the data (P <0.05). In addition, the disappearance time of all indexes in the observation group was also shorter than that in the control group (P <0.05). Conclusion: Combination of Pulmicort respules and Kebite (nebulized) can achieve the desired effect in the treatment of asthmatic bronchitis, and its use value is great and the effect is obvious.